Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis

@article{Gorter2016RightVD,
  title={Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis},
  author={Thomas M. Gorter and Elke S. Hoendermis and Dirk J. van Veldhuisen and Adriaan A. Voors and Carolyn S. P. Lam and Bastiaan Geelhoed and Tineke P. Willems and Joost P. van Melle},
  journal={European Journal of Heart Failure},
  year={2016},
  volume={18}
}
Right ventricular (RV) dysfunction and pulmonary hypertension (PH) are increasingly recognized in heart failure with preserved ejection fraction (HFpEF). The prevalence and prognostic value of RV dysfunction in HFpEF have been widely but variably reported. We therefore conducted a systematic review and meta‐analysis according to Preferred Reporting Items for Systematic Reviews and Meta‐Analyses. 
Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
TLDR
The extent and clinical correlates of diffuse RV myocardial fibrosis in PH‐HFpEF, as measured by cardiovascular magnetic resonance‐derived extracellular volume (ECV), are evaluated.
Right ventricular dysfunction in left‐sided heart failure with preserved versus reduced ejection fraction
Right ventricular (RV) dysfunction is recognized as a major prognostic factor in left‐sided heart failure (HF). However, the relative contribution of RV dysfunction in HF with preserved (HFpEF) vs.
Right ventricular dysfunction in heart failure with reduced vs. preserved ejection fraction: non‐identical twins?
TLDR
Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction are referred to.
Predictive value of heart failure with reduced versus preserved ejection fraction for outcome in pulmonary embolism
This study aimed to investigate whether the risk of short‐term mortality is different in pulmonary embolism (PE) patients who have heart failure with reduced ejection fraction (HFrEF) as compared
Fibrosis‐4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction
TLDR
This work investigated the prognostic implication of the FIB‐4 index regarding right ventricular dysfunction in patients with HFpEF and found it unclear whether this index is associated with right‐sided heart failure or not.
Prominent ‘Y’ descent is an ominous sign of a poorer prognosis in heart failure with preserved ejection fraction
TLDR
This study aimed to clarify whether impaired RV distensibility is associated with the deterioration of HFpEF, and confirmed that RV afterload is not a major cause of deterioration inHFpEF.
Right ventricular dysfunction and pulmonary hypertension in heart failure with preserved ejection fraction
TLDR
The findings of a comprehensive systematic review and meta-analysis aimed at clarifying the prevalence and prognostic value of RVD and PH in HFpEF are presented.
Distinctive prognostic factor of heart failure with preserved ejection fraction stratified with admission blood pressure
TLDR
The pathophysiological differences between patients categorized with admission SBP among patients with preserved ejection fraction with HFpEF patients are clarified to clarify the prognostic importance of admission systolic blood pressure.
CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
The article discusses modern representation about the mechanisms of development, the results of recently completed and the background for  new studies of methods for treating chronic heart failure
The prevalence, predictors, and prognosis of tricuspid regurgitation in stage B and C heart failure with preserved ejection fraction
TLDR
This study aimed to investigate the prevalence and prognosis of TR in patients with HFpEF, finding that moderate/severe tricuspid regurgitation is associated with adverse outcome in patientswith heart failure with reduced ejection fraction.
...
...

References

SHOWING 1-10 OF 96 REFERENCES
The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics
TLDR
This data indicates that right ventricular systolic dysfunction by cardiac magnetic resonance imaging (CMR) is a strong predictor of outcome in heart failure with preserved ejection fraction (HFpEF), but the prognostic significance of RVSD by CMR in heart failures with preserved ejectedion fraction is unknown.
New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study
TLDR
To identify electrocardiographic and echocardiographic predictors of mortality and hospitalizations for heart failure (HF) in the KaRen study, data are analyzed through positron emission tomography and EMT.
It Is Time to Look at Heart Failure With Preserved Ejection Fraction From the Right Side
TLDR
Careful delineation of HFpEF subphenotypes on the basis of predominant pathophysiologic inputs may improve diagnostic classification, guide targeted therapy, and ultimately improve clinical outcome.
Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
TLDR
Improved characterization of the large subset of HFpEF patients with RVD, with and without antecedent pulmonary hypertension may yield critical insights, which inform novel therapeutic interventions.
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction: A Community-Based Study
TLDR
In the community, RVD is common in HFpEF patients, is associated with clinical and echocardiographic evidence of more advanced HF, and is predictive of poorer outcomes.
Association between cardiovascular vs. non‐cardiovascular co‐morbidities and outcomes in heart failure with preserved ejection fraction
The prevalence of cardiovascular and non‐cardiovascular co‐morbidities and their relative importance for outcomes in heart failure with preserved ejection fraction (HFPEF) remain poorly
Right heart dysfunction in heart failure with preserved ejection fraction.
TLDR
Right heart dysfunction is common in HFpEF and is caused by both RV contractile impairment and afterload mismatch from pulmonary hypertension, and may represent a novel therapeutic target.
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
TLDR
The multifaceted response to phosphodiesterase-5 inhibition in heart failure with preserved ejection fraction includes improvement in pulmonary pressure and vasomotility, RV function and dimension, left ventricular relaxation and distensibility (structural changes and/or ventricular interdependence), and lung interstitial water metabolism.
Prevalence, Determinants, and Prognostic Significance of Pulmonary Hypertension in Elderly Patients Admitted with Acute Decompensated Heart Failure: A Report from the BIO‐HF Registry
Pulmonary hypertension (PHT) is a predictor of mortality and morbidity in patients with chronic heart failure (HF). However, the prevalence, determinants, and prognostic significance of PHT in
...
...